Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1998
11/04/1998EP0874645A2 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
11/04/1998EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0776328B1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them
11/04/1998EP0696270B1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/04/1998EP0602144B1 Dna sequences encoding gelonin polypeptide
11/04/1998CN1198165A Modulators of function of FAS receptors and other proteins
11/04/1998CN1198164A Novel water-soluble C-ring analogues of 20(s)-camptothecin
11/04/1998CN1198158A Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
11/04/1998CN1197799A Mesoplatinum complex and its synthesis
11/04/1998CN1040540C Anthracene ring antibiotic thioether conjugates, its prepn. and pharmaceutical composition containing same
11/03/1998US5831115 Inhibitors of squalene synthase and protein farnesyltransferase
11/03/1998US5831088 Osmylation
11/03/1998US5831072 Inhibitor of deaminase
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831048 Grb3-3 cDNA and polypeptides
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5831009 Protein phosphotyrosine phosphatases PTP-D1
11/03/1998US5831008 Retinoblastoma protein-interacting zinc finger proteins
11/03/1998US5831002 Hybrid polypeptide
11/03/1998US5830995 Fanphiregulins: a family of heparin-binding epithelial cell growth factors
11/03/1998US5830914 Apoptosis-controlling agent
11/03/1998US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830886 Steroid sulphatase inhibitors
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830872 Esters of D-mannose or of xylitol and their use as medicaments
11/03/1998US5830755 T-cell receptors and their use in therapeutic and diagnostic methods
11/03/1998US5830753 Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830686 Gene expression
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998US5830660 Tumorigenesis protein
11/03/1998US5830646 Diagnostic method
11/03/1998US5830473 Antibodies against T cells as therapeutics
11/03/1998US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998US5830464 Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830448 Compositions and methods for the treatment of tumors
11/03/1998US5830431 Radiolabeled peptide compositions for site-specific targeting
11/03/1998US5829448 Method for improved selectivity in photo-activation of molecular agents
11/03/1998CA1340112C Supression of cell proliferation by decorin
10/1998
10/30/1998CA2236254A1 Process for preparing benzo¬b|thiophenes
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998047911A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998WO1998047861A1 Retinoid-like compounds
10/29/1998WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998WO1998047538A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
10/29/1998WO1998047537A1 Polymer-platinum compounds
10/29/1998WO1998047524A1 Gastrin receptor-avid peptide conjugates
10/29/1998WO1998047512A1 1,2,4-benzotriazine oxides formulations
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998WO1998033470A3 Substituted perylenequinones for use in photodynamic therapy
10/29/1998WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998DE19717904A1 Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie Acid labile and enzymatically cleavable dye constructs for diagnosis and therapy with near-infrared light
10/29/1998CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998CA2287314A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998CA2286865A1 Edg-1-like receptor
10/29/1998CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998CA2286252A1 Retinoid-like compounds
10/29/1998CA2283854A1 Gastrin receptor-avid peptide conjugates
10/28/1998EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells
10/28/1998EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998EP0873424A1 Metastasis inducing dna's
10/28/1998EP0873407A1 Apo-2 ligand
10/28/1998EP0873355A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione
10/28/1998EP0873349A1 Endothelial-monocyte activating polypeptide iii
10/28/1998EP0873347A2 Novel amine derivatives of epipodophyllotoxin 2", 3"-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer
10/28/1998EP0873341A1 Epothilone derivatives, preparation and use
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873335A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER
10/28/1998EP0873332A1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy
10/28/1998EP0873315A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
10/28/1998EP0873312A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873304A1 Metalloproteinase inhibitors
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0873139A1 Antibodies with reduced net positive charge
10/28/1998EP0873137A1 Compositions including calcium influx blockers for inhibiting cell growth
10/28/1998EP0873123A1 Inhibitors of protein isoprenyl transferases
10/28/1998EP0873122A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
10/28/1998EP0873119A1 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
10/28/1998EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998EP0759742B1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
10/28/1998CN1197453A 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
10/28/1998CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
10/28/1998CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827900 Administering lycopene
10/27/1998US5827895 Inhibiting the infection of staphylococcus or mycobacterium by administering a cyclohexane-diketone-diols; anticarcinogenic agents
10/27/1998US5827892 Treatment and prevention of atherosclerosis
10/27/1998US5827890 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
1 ... 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 ... 2211